Single View

Contact

Dr. Eleonora SchönherrPresse- & ÖffentlichkeitsarbeitPhone: +49 40 42818-269
Mail: presse(at)bnitm.de

Julia HäberleinPresse- & ÖffentlichkeitsarbeitPhone: +49 40 42818-264
Mail: presse(at)bnitm.de

| 20.04.2021

World Malaria Day April 25, 2021

Our interview partners for journalists can be found below.

In 2000, the World Health Organization (WHO) established the World Malaria Day as an annual international day of action. Its purpose is to remind that more than three billion people in the world are at risk from malaria. The WHO and other organizations are working to roll back this infectious disease at great financial and logistical expense. This has led to a reduction in new cases in recent years. However, for the first-time last year, the WHO recorded an increase to around 230 million malaria cases worldwide, of which more than 400,000 were fatal. Children under the age of five in Africa account for more than two-thirds of the deaths. Our interview partners for journalists can be found below.The Bernhard Nocht Institute for Tropical Medicine (BNITM) in Hamburg is dedicated to malaria research. The spectrum ranges from molecular studies of the malaria parasite and research into its spread and clinical course to vaccination and drug studies in Africa. For example, in order to be able to test an antimalarial therapy with a next-generation triple combination, BNITM is conducting a multicenter clinical trial in four African Countries (Ghana, Mali, Gabon and Benin) together with the Kumasi Centre for Collaborative Research (KCCR) in Ghana. The focus here is on the efficacy and safety of an antimalarial treatment that is vital, especially for children in sub-Saharan Africa. "In Southeast Asia, the efficacy of proven artemisinin-based combination therapies has already declined significantly due to the emergence of artemisinin-resistant strains," warns Dr. Oumou Maiga-Ascofaré, project coordinator at KCCR and BNITM. "Resistant strains may also spread in Africa and compromise efforts already achieved in reducing the burden caused by Malaria," she adds. Further development of new drug combinations is therefore urgently needed before artemisinin-resistant malaria strains spread widely throughout Africa, she sais.

Read more about malaria in the context of COVID-19 and Global Health on our Day of Action website here.

BNITM expert service on the occasion of World Malaria Day 2021

On the occasion of World Malaria Day, the scientists listed are available for interviews free of charge to members of the press today and on April 25:

Prof. Dr. Egbert Tannich
Chair Board of Directors; Parasitology and Diagnostics
Tel.: 0049-40-42818-260
E-Mail: tannich(at)bnitm.de

Prof. Dr. Jürgen May (BNITM) / Dr. Oumou Maiga-Ascofaré (KCCR)
Epidemiology; Malaria in Africa; Medication development
Tel.: 0049-40-42818-369
E-Mail: may(at)bnitm.de
E-Mail: maiga(at)bnitm.de

Prof. Dr. Michael Ramharter
Clinical research of Malaria; Treatment; Prophylaxis, Vaccination studies
Tel.: 0049-40-42818-1330, -264
E-Mail: presse(at)bnitm.de

Dr. Tobias Spielmann
Milestones in laboratory research
Tel.: 0049-40-42818-486
E-Mail: spielmann(at)bnitm.de


Logo Mitglied der Leibniz Gemeinschaft